Breast Cancer and Hormonal Stimulation: Is Glycolysis the First Sign of Response?: FIGURE 1.
Year: 2010
Type: article
Abstract: The estrogen receptor (ER) is a critical therapeutic target for breast cancer. Nearly 70% of newly diagnosed breast cancers express ER, and frequent dependence of breast cancer on estrogen stimulation for growth makes endocrine therapy an attractive choice for breast cancer treatment. Multiple
Source: Journal of Nuclear Medicine
Authors: Hannah M. Linden, David A. Mankoff
Institutions: Seattle Cancer Care Alliance, University of Washington
Language: English
Subfield: Endocrinology
Domain: Life Sciences
Open Access status: bronze
OpenAlex ID: W1967912865
